Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/1/1999


1.		Randomized Study of Pentoxifylline and Best Supportive Care vs Best Supportive Care Only for Radiation-Induced Soft Tissue Necrosis in Cancer Patients (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				RTOG-9407 RTOG 94-07

Last Modified: 7/1/1998 First Published: 10/1/1997


2.		Phase III Double Blind, Placebo Controlled, Randomized Study of the Effectiveness of Pentoxifylline in Maintaining Weight in Patients Undergoing Chemotherapy for Metastatic Cancer (Summary Last Modified 07/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				URCC-U2994 URCC-2994PM, NCI-P97-0087

Last Modified: 8/1/1998 First Published: 8/1/1998


3.		Phase III Randomized Study of Pentoxifylline, Ciprofloxacin, and Dexamethasone Versus Amifostine in Patients with Myelodysplastic Syndromes (Summary Last Modified 08/1998)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				21 and over				Pharmaceutical / Industry				BOSTON-VAMC-523 ALZA-97-047-ii, NCI-V98-1422

Last Modified: 6/1/1994


4.		Phase I/II Study of BU/CTX plus Autologous or Syngeneic Bone Marrow Transplantation or Peripheral Blood Stem Cell Rescue in Patients with Advanced Multiple Myeloma (Summary Last Modified 06/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 65								FHCRC-336.3 NCI-V88-0470

Last Modified: 6/1/1994


5.		Phase I/II Trial of IL-2 with or without Pentoxifylline in Patients with Disseminated Cancer (Summary Last Modified 06/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Completed				16 and over				NCI				PCI-9207 NCI-T92-00580

Last Modified: 12/1/1997


6.		Phase II Study of PTX and GM-CSF to Reduce Early Posttransplant Mortality/Morbidity from Veno-occlusive Disease and Infection Following a Second Marrow Transplant for Lymphoid and Myeloid Malignancies Treated with TBI at First Transplant (Summary Last Modified 12/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				11 to 50				NCI				FHCRC-176.05 NCI-H94-0375

Last Modified: 12/1/1994


7.		Phase II Study of Anti-TNF Therapy with PTX and CPFX in Patients Undergoing Ablative Chemoradiotherapy/Allogeneic Bone Marrow Transplantation for AML in First or Second Remission or First Relapse (Summary Last Modified 12/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				17 to 55								FHCRC-601.0 NCI-V94-0382

Last Modified: 3/1/1998


8.		Phase II Randomized Pilot Study of Pentoxifylline vs Placebo for Anorexia and Cachexia in Patients with Metastatic Malignancies (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				adult				NCI				SWOG-9327 NCI-P94-0058

Last Modified: 5/7/2007 First Published: 8/1/2001


9.		Phase II Randomized Study of Vitamin E and Pentoxifylline in Patients With Lymphedema After Radiotherapy for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				Not specified				Other				RM-1597 EU-20050, NCT00022204

Last Modified: 9/1/1991


10.		Phase II Randomized Study of Crossover Therapy with DOX vs Pentoxifylline/Thiotepa in Patients with Metastatic Prostate Carcinoma Refractory to Hormonal Manipulation and Suramin (Summary Last Modified 09/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				NCI-91-C-120B NCI-CPB-270, NCI-T91-0022N, T91-0022

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute